UK markets close in 5 hours 5 minutes
  • FTSE 100

    7,090.22
    +27.93 (+0.40%)
     
  • FTSE 250

    22,565.92
    +108.84 (+0.48%)
     
  • AIM

    1,219.50
    -1.51 (-0.12%)
     
  • GBP/EUR

    1.1669
    -0.0019 (-0.17%)
     
  • GBP/USD

    1.3876
    -0.0057 (-0.41%)
     
  • BTC-GBP

    22,734.84
    -928.10 (-3.92%)
     
  • CMC Crypto 200

    750.62
    -99.72 (-11.73%)
     
  • S&P 500

    4,224.79
    +58.34 (+1.40%)
     
  • DOW

    33,876.97
    +586.89 (+1.76%)
     
  • CRUDE OIL

    73.29
    -0.37 (-0.50%)
     
  • GOLD FUTURES

    1,783.20
    +0.30 (+0.02%)
     
  • NIKKEI 225

    28,884.13
    +873.20 (+3.12%)
     
  • HANG SENG

    28,309.76
    -179.24 (-0.63%)
     
  • DAX

    15,600.12
    -3.12 (-0.02%)
     
  • CAC 40

    6,608.61
    +6.07 (+0.09%)
     

Gilead Sciences to Present at Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
  • Oops!
    Something went wrong.
    Please try again later.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

  • Cowen Annual Virtual Oncology Innovation Summit on Friday, May 21 at 12:00pm ET

  • Jefferies Virtual Healthcare Conference on Tuesday, June 1 at 1:30pm ET

  • Bernstein Annual Strategic Decisions Conference on Wednesday, June 2 at 4:30pm ET

  • Goldman Sachs Annual Global Healthcare Conference on Wednesday, June 9 at 2:10pm ET

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210514005524/en/

Contacts

Jacquie Ross, Investors
(650) 358-1054

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting